METHOD FOR DETECTING Acsl1 GENE SENSITIVE TO HIGH-LEVEL IONIZING RADIATION

ABSTRACT

A method for detecting genes sensitive to high-level ionizing radiation and genes detected by the method. More specifically, genes sensitive to high-level ionizing radiation discovered in a carcinogenic entity and verified in a normal entity are detected, by subjecting a cancerous AKR/J mouse and a normal ICR mouse to high-level radiation. Thymus is collected therefrom and fatty acid metabolism-related genes are classified via microarray processing of the thymus. The genes are amplified and the levels of gene expression are measured. Thus, the present invention allows a gene having a specific reaction to radiation to be accurately detected by preventing the interference of confounding variables.

RELATED APPLICATIONS

This application is a division of U.S. application Ser. No. 14/399,952filed on Nov. 9, 2014, which claims the benefit under § 371 applicationfrom PCT/KR2012/003899 filed May 17, 2012, which claims priority fromKorean Patent Application No. 10-2012-0049588 filed May 10, 2012, eachof which is herein incorporated by reference in its entirety.

REFERENCE TO ELECTRONIC SEQUENCE

The contents of electronic sequence listing (40D5712.txt; Size: 2kilobytes; and Date of Creation: Apr. 18, 2018) is herein incorporatedby reference in its entirety.

TECHNICAL FIELD

The present invention relates to a method for detecting genes sensitiveto a high level of ionizing radiation and genes detected by the method,and more particularly, to a method for detecting genes sensitive to ahigh level of ionizing radiation, the method including irradiatingcancer-induced mice and normal mice with a high level of radiation, andscreening fatty acid metabolism-related genes, which are observedcommonly in the normal mice and the cancer-induced mice, from the thymiof the mice.

BACKGROUND ART

With an increase in the industrial and medical use of radiation, variousstudies on the effects of radiation on the human body have beenconducted, and particularly, cancer therapy with radiation has receivedattention. It is known that high doses of ionizing radiation cause DNAdamage, genetic modification, and diseases, including cancer, but aradiation dose of 200 mGy or less and a radiation dose rate of 6 mGy/hror less inhibit cancer development by activating immune responses.

In general, studies on the relationship between radiation and cancerdevelopment, particularly gene responses to radiation, have beenconducted, but confounding factors have significantly affected theresults to reduce the reliability of the results. However, most studiesconducted to date could not explain various responses, which occur inthe cells, tissues and organs of the body in the body stage, becausethese studies were performed using gene-modified cell lines or cancercell lines. In other words, because gene responses were evaluated usinggeneral mice, a variety of genes were expressed, and because cancerdevelopment was not limited to a specific organ, it was difficult toanalyze gene responses.

In prior art methods that use cells for cancer research, genes weremodified, or cancer cells lacking p53 that is important in cancerdevelopment were irradiated. For this reason, there was a problem inthat the results could not be applied to individuals, because they didfundamentally differ from the responses of normal cells. To overcomethis problem, studies on the effects of radiation on cancer developmenthave been conducted using mice having a gene similarity of 95% or morewith humans. However, cancer incidence in general mice is very low, andthus a variety of mouse models for cancer research have been used.

In the prior art, a variety of methods were used to screen fatty acidmetabolism-related genes sensitive to ionizing radiation. However, fattyacid metabolism-related genes disclosed in the present invention are notyet known as genes sensitive to a high level of ionizing radiation.Technologies prior to the identification of the profile of genesaccording to the present invention are as follows.

(1) Ppargc1a is known as a member of biorhythm regulator and known toplay an important role in biorhythm and energy metabolism (Liu C et.al., Nature 2007; 447:477-481).

(2) Ppargc1a activated mitochondrial biosynthesis in type endometrialcancer (Cormio A et. al., Biochem Biophus Res Commum 2009; 390:1182-1185).

(3) The interaction between Acsl1 and FATP1 in adipocytes increased theuptake of long-chain fatty acids (Richards M R et. al., J Lipid Res2006; 47: 665-72).

(4) Injection of Acsl1 inserted into adenovirus increased theaccumulation of adipose in C57BL6 mice and Wistar rats (Parkes H A et.al., Am J Physiol Endocrinol Metab 2006; 291:E737-744).

(5) Lipe is known as a rate limiting enzyme for diacylglycerol andcholesteryl ester hydrolysis in adipocytes (Holm C et. al., Science1998; 241: 1503-1506).

(6) Activation of EPK signaling in adipocytes stimulated lypolysisthrough HSL phosphorylation (Greenberg A S et. al., J Biol Chem 2001;276: 45456-454561).

(7) Inhibition of HSL expression in pancreatic islets reduced insulinsecretion (Larsson, 2008).

(8) Scd is known as a rate limiting enzyme that is involved in thesynthesis of unsaturated fatty acids from saturated fatty acids (NtambiJ M, Miyazaki M, Prog Lipid Res 2004; 43: 91-104; Flowers M T, Ntambi JM, Curr Opin Lipidol 2008; 19: 248-256).

(9) Cancer cells activated Scd1 to regulate the synthesis ofsugar-linked lipids. However, when the function of Scd1 was abnormal,acetyl-CoA carboxylase activity was inhibited by AMPK, and the synthesisand accumulation of saturated fatty acids were inhibited (Scaglia N et.al. (2009) PLoS One 4: e6812).

Accordingly, the present inventors have identified the profile of fattyacid metabolism-related genes sensitive to a high level of ionizingradiation, thereby completing the present invention.

DISCLOSURE Technical Problem

It is an object of the present invention to provide a method fordetecting a gene sensitive to a high level of ionizing radiation, and agene detected by the method.

Technical Solution

In order to accomplish the above object, the present invention providesa method for detecting a gene that is sensitive to a high level ofionizing radiation and is identified in a cancer-induced individual andverified using a normal individual, the method including the steps of:I) irradiating an AKR/J mouse and an ICR mouse with a high level ofradiation; II) extracting thymi from the AKR/J mice and the ICR mice;III) subjecting the thymi to microarray analysis; IV) selecting a fattyacid metabolism-related gene from the microarray analysis; and V)amplifying the gene and measuring the expression level of the gene.

The present invention also provides a marker for diagnosing aradiation-sensitive or radiation-induced cancer, the marker includingthe nucleotide sequence of a fatty acid metabolism-related gene selectedfrom the group consisting of Ppargc1a (NM_008904), Acsl1 (NM_007981),Lipe (NM_010719), Scd1 (NM_009127) and Scd3 (NM_024450), which areinvolved in worsening of thymic cancer.

The present invention also provides a kit for diagnosing aradiation-sensitive or radiation-induced cancer, the kit including theabove marker.

The present invention also provides a microarray for diagnosing aradiation-sensitive or radiation-induced cancer, the microarrayincluding the above marker.

The present invention also provides a method for screening a drug fortreating or inhibiting a radiation-sensitive or radiation-inducedcancer, the method including the steps of: I) irradiating a mammalhaving thymic cancer with radiation; II) bringing a test substance intocontact with a thymic tissue extracted from the irradiated mammal; andIII) measuring, from the thymic tissue, a change in the expression of afatty acid metabolism-related gene selected from the group consisting ofPpargc1a (NM_008904), Acsl1 (NM_007981), Lipe (NM_010719), Scd1(NM_009127) and Scd3 (NM_024450), which are involved in worsening ofthymic cancer.

Hereinafter, the present invention will be described in detail.

Many studies on the effects of radiation on cancer development among theeffects of radiation on the human body have been conducted, but it wasdifficult to explain various responses of the body to radiation(responses of genes to radiation), because these studies were performedusing cancer cells, gene-modified cell lines or general mice.Particularly, the profile of fatty acid metabolism-related genessensitive to ionizing radiation in individuals has not yet beenidentified, and the functions of these genes have not been explained.Accordingly, the present invention is intended to (1) identify theprofile of fatty acid metabolism-related genes that are expressedspecifically in thymus and sensitive to a high level of radiation, andanalyze the functions of the genes, after irradiating a high level (0.8Gy/min) of radiation (cancer development stimulator) to normal ICR miceand AKR/J mice that develop thymic cancer, and 2) diagnose the stage ofdevelopment of thymic cancer using the profile of fatty acidmetabolism-related genes.

The present invention provides a method for detecting a gene that issensitive to a high level of ionizing radiation and is identified in acancer-induced individual and verified using a normal individual, themethod including the steps of: I) irradiating an AKR/J mouse and an ICRmouse with a high level of radiation; II) extracting thymi from theAKR/J mice and the ICR mice; III) subjecting the thymi to microarrayanalysis; IV) selecting a fatty acid metabolism-related gene from themicroarray analysis; and V) amplifying the gene and measuring theexpression level of the gene.

In the inventive method for detecting a gene sensitive to a high levelof ionizing radiation, irradiating the mouse with the high level ofradiation is preferably perfoLmed by irradiating gamma radiation(Cs-137) at a dose rate of 0.8 Gy/min to a final dose of 4.5 Gy. Themethod according to the present invention is preferably used forpreparation of a kit for diagnosing thymic cancer, evaluation of thedegrees of progression and treatment of cancer in a cancer patient,evaluation of the relationship between radiation exposure of industrialand medical workers and cancer development, evaluation of the causalrelation between radiation and cancer development, biological evaluationof radiation exposure dose, or evaluation of the degrees of developmentand progression of thymic cancer caused by a high level of radiation.

In addition, the inventive method for detecting a gene sensitive to ahigh level of ionizing radiation, the cancer is preferably thymiccancer, and extracting the thymi in step II) is preferably performed ata time point when the mouse starts to die of the cancer.

Furthermore, in the inventive method for detecting a gene sensitive to ahigh level of ionizing radiation, the fatty acid metabolism-related geneis preferably selected from the group consisting of Ppargc1a(NM_008904), Acsl1 (NM_007981), Lipe (NM_010719), Scd1 (NM_009127) andScd3 (NM_024450). Preferably, the Ppargc1a (NM_008904) gene is amplifiedusing primers having sequences set forth in SEQ ID NOS: 1 and 2; theAcsl1 (NM_007981) gene is amplified using primers having sequences setforth in SEQ ID NOS: 3 and 4; the Lipe (NM_010719) gene is amplifiedusing primers having sequences set forth in SEQ ID NOS: 5 and 6; theScd1 (NM_009127) gene is amplified using primers having sequences setforth in SEQ ID NOS: 7 and 8; and the Scd3 (NM_024450) gene is amplifiedusing primers having sequences set forth in SEQ ID NOS: 9 and 10.

In step IV) of selecting the fatty acid metabolism-related gene from themicroarray analysis, a gene overexpressed or underexpressed in thecancer-induced individual after irradiation compared to in thecancer-induced individual before irradiation is detected by microarrayanalysis, and then verified using primers having sequences of SEQ IDNOS: 1 to 10, and the overexpressed or underexpressed gene is identifiedby performing a search for the function thereof. The microarray analysisis described in the Examples below, and a search for the function of thegene was performed in the Examples through the DAVID bioinfoimaticsdatabase and (apps1.niaid.nih.gov) and the PubMed database(ncbi.nlm.nih.gov), but is not limited thereto.

As used herein, “gene sensitive to a high level of radiation” refers toa gene that is differentially overexpressed or underexpressed in acancer-induced individual after radiation compared to beforeirradiation. In other words, the gene refers to a gene whose expressionpattern is changed by stimulation with radiation, and it may be a targetgene associated with a specific cancer, that is, an oncogene or a tumorsuppressor gene. When this cancer-specific gene is detected, a molecularmechanism for radiotherapy of cancer patients can be established, whichcan contribute to an increase in the effect of radiotherapy, and aplatform for the development of agents or methods for treating cancer atthe biomolecular level can be provided by screening novel oncogenes ortumor suppressor genes and regulating the expression thereof.

The present invention also provides a marker for diagnosing aradiation-sensitive or radiation-induced cancer, the marker includingthe nucleotide sequence of a gene selected from the group consisting ofPpargc1a (NM_008904), Acsl1 (NM_007981), Lipe (NM_010719), Scd1(NM_009127) and Scd3 (NM_024450), which are involved in worsening ofthymic cancer.

The present invention also provides a kit for diagnosing aradiation-sensitive or radiation-induced cancer, the kit including theabove marker.

The present invention also provides a microarray for diagnosing aradiation-sensitive or radiation-induced cancer, the microarrayincluding the above marker.

The present invention also provides a method for screening a drug fortreating or inhibiting a radiation-sensitive or radiation-inducedcancer, the method including the steps of: I) irradiating a mammalhaving thymic cancer with radiation; II) bringing a test substance intocontact with a thymic tissue extracted from the irradiated mammal; andIII) measuring, from the thymic tissue, a change in the expression of afatty acid metabolism-related gene selected from the group consisting ofPpargc1a (NM_008904), Acsl1 (NM_007981), Lipe (NM_010719), Scd1(NM_009127) and Scd3 (NM_024450), which are involved in worsening ofthymic cancer.

In the present invention, AKR/J mice (models for thymic cancer research)and healthy ICR mice were irradiated with a high level (0.8 Gy/min) ofgamma radiation (Cs-137), and thymi were extracted from the mice at atime point (day 100) when the AKR/J mice started to die of thymiccancer. The extracted thymi were analyzed by microarray analysis, andthen fatty acid metabolism-related genes that responded sensitively tothe high level of radiation (0.8 Gy/min) were selected through the DAVIDbioinformatics database, and subjected to nucleic acid amplification,and the expression levels thereof were measured.

As a result, five genes (Ppargc1a, Acsl1, Lipe, Scd1 and Scd3), whichresponded sensitively to the high level of radiation (0.8 Gy/min) andare important in fatty acid metabolism, were screened in the presentinvention, and the functions of the fatty acid metabolism-related genes(Ppargc1a, Acsl1, Lipe, Scd1 and Scd3) that responded sensitively to thehigh level of radiation (0.8 Gy/min) were elucidated. In addition, thefatty acid metabolism-related genes responding sensitively to the highlevel of radiation could be consistently observed by extracting thymi atday 100 when death caused by thymic cancer was observed.

Therefore, the present invention may be used to: (1) identify theprofile of genes for development of a kit for diagnosing thymic cancer;(2) identify a marker for evaluating the relation of cause and effect ofcancer development in industrial and medical workers who live inenvironments having a low level of radiation; (3) identify the profileof genes for information, which enable the diagnosis of cancerdevelopment in cancer patients and allow a cancer therapeutic method tobe established; (4) identify a marker for evaluating the causal relationbetween radiation exposure and the development of thymic cancer; 5)identify a novel gene marker that may be widely used for biologicalevaluation of a high level of radiation exposure; and (6) understandionizing radiation-sensitive fatty acid metabolism signaling that may beused as a target therapy for a high level of radiation exposure.

Advantageous Effects

The method for detecting a gene sensitive to a high level of ionizingradiation as described above may be used to establish the profile offatty acid metabolism-related marker genes sensitive to a high level ofradiation in order to prepare a kit for diagnosing thymic cancer, andmay provide a fatty acid metabolism-related marker gene sensitive to ahigh level of radiation, which can be used to evaluate the degrees ofprogression and progression of cancer in cancer patients. Also, themethod according to the present invention may provide a fatty acidmetabolism-related marker gene sensitive to a high level of radiation,which can be used to evaluate the relationship between the radiationexposure of industrial and medical workers and cancer development.Further, it may provide a fatty acid metabolism-related marker sensitiveto a high level of radiation, which can be used to evaluate the causalrelation between radiation and cancer development. In addition, it mayprovide a novel marker that can be used for biological evaluation ofradiation exposure dose. Also, it may provide a fatty acidmetabolism-related marker that can be used to evaluate the degrees ofdevelopment and progression of thymic cancer caused by a high level (0.8Gy/min) of radiation.

DESCRIPTION OF DRAWINGS

FIG. 1 schematically shows the functions of fatty acidmetabolism-related genes (Ppargc1a, Acsl1, Lipe, Scd1 and Scd3) thatworsen thymic cancer upon irradiation with a high level (0.8 Gy/min) ofradiation.

FIG. 2 is a graph showing the results obtained by irradiating AKR/J micewith a high level (0.8 Gy/min) of radiation and measuring the weight ofthymi of the mice at a time point (day 100) when the mice started to dieof thymic cancer during their housing, in order to analyze the responsesof fatty acid metabolism-related genes sensitive to radiation based onthe thymus weight.

MODE FOR INVENTION

Hereinafter, the present invention will be described in further detailwith reference to examples. It is to be understood, however, that theseexamples are for illustrative purposes only and are not intended tolimit the scope of the present invention.

Example 1

6-Week-old female AKR/J mice (models for thymic cancer research) and6-week-old female ICR mice were purchased from SLC Co., Ltd. (Japan). Ahigh level of radiation (¹³⁷Cs) was irradiated to the AKR/J mice using agamma-ray generator (IBL 147C, CIS bio international, France) at a doserate of 0.8 Gy/min) so as to reach a final dose of 4.5 Gy. Aftercompletion of irradiation with the high level of radiation, the micewere transferred into a sterilized housing system shielded fromradiation, and were housed therein for 100 days while the observation ofdevelopment of thymic cancer was performed. For gene analysis, under thesame experimental conditions, normal mice (ICR mice) housed separatelyfrom the AKR/J mice were irradiated with a high level of radiation (0.8Gy/min). After 100 days, thymi were extracted from the mice and frozenrapidly in liquid nitrogen, after which gene analysis was performed.

Example 2: Microarray and Gene Analysis

Using mouse models (AKR/J mice) for cancer research, irradiated inExample 1, fatty acid metabolism-related genes sensitive to a high levelof radiation (0.8 Gy/min) were screened. The screened genes wereverified using normal mice (ICR mice). Specifically, fatty acidmetabolism-related genes that responded to a high level of radiation(0.8 Gy/min) specifically in the thymi of the AKR/J and ICR miceirradiated with the high level of radiation were screened, and theirfunctions were analyzed. Analysis was performed using the DAVIDbioinformatics database, a quantitative nucleic acid amplificationtechnique, and the statistical program SAS (ANOVA and t-test).

To confirm the results, the genes were subjected to nucleic acidamplification. Specifically, the thymi extracted from the AKR/J and ICRmice irradiated with the high level of radiation (0.8 Gy/min) weremicroarrayed, and fatty acid metabolism-related genes that respondedsensitively to the high level of radiation were amplified using theprimers shown in Table 1 below in order to measure the expression levelsthereof.

TABLE 1 ID Number Gene No. Gene name Forward (5′→3′) Reverse (5′→3′)SEQ ID NO: 1 NM_008904 Ppargc1a ACCGTAAATCTGCGGGATGAT GGA SEQ ID NO: 2NM_008904 Ppargc1a AGTCAGTTTCGTTCGACCTGC GTA SEQ ID NO: 3 NM_007981Acs11 AAGCCGGTCTGAAGCCATTTG AAC SEQ ID NO: 4 NM_007981 Acs11TCGCCTTCAGTGTTGGAGTCA GAA SEQ ID NO: 5 NM_010719 LipeATCCCAGGCTCACAGTTACC SEQ ID NO: 6 NM_010719 Lipe TCCTTCCCGTAGGTCATAGGSEQ ID NO: 7 NM_009127 Scd1 CTCCTGCTGATGTGCTTCAT SEQ ID NO: 8 NM_009127Scd1 AAGGTGCTAACGAACAGGCT SEQ ID NO: 9 NM_024450 Scd3CTGCTGATGTGCTTCATCCT SEQ ID NO: 10 NM_024450 Scd3 AGCACCACAGCGTATCTCAG

After irradiation of the AKR/J and ICR mice with the high level ofradiation (0.8 Gy/min), the mice were housed, and thymi were extractedfrom the mice at a time point (day 100) when the AKR/J mice started todie of thymic cancer. The extracted thymi were microarrayed, and fattyacid metabolism-related genes that responded sensitively to the highlevel of radiation were selected, and then subjected to nucleic acidamplification, and the expression levels thereof were measured. As aresult, it was shown that, in the mice irradiated with the high level ofradiation, fatty acid metabolism-related genes (Ppargc1a, Acsl1, Lipe,Scd1 and Scd3) responded sensitively to the high level of radiation. Theresults are shown in Table 2 below.

TABLE 2 Quantitative nucleic Microarray amplification ICR AKR/J ICRAKR/J Gene No. Gene name mice mice mice mice NM_008904 Ppargc1a 0.6 1.4 4.5 ± 1.5* 2.4 ± 1.6 NM_007981 Acsl1 1.0 1.3 4.8 ± 1.7 2.6 ± 1.3NM_010719 Lipe 1.5 1.2 2.7 ± 0.9 1.5 ± 0.3 NM_009127 Scd1 0.9 3.7 20.7 ±15.9 3.7 ± 4.6 NM_024450 Scd3 0.9 1.9 1.4 ± 0.4 3.0 ± 1.0 *Expressionfold value ± SD

FIG. 1 schematically shows the functions of fatty acidmetabolism-related genes (Ppargc1a, Acsl1, Lipe, Scd1 and Scd3) thatworsen thymic cancer due to irradiation with a high level of radiation(0.8 Gy/min). As can be seen therein, the high level of radiationincreased the expression of Acsl1, resulting in an increase in theuptake of long-chain fatty acids into thymocytes. Increases in theexpression levels of Scd1 and Scd3 inhibited the accumulation ofsaturated fatty acids, and reduced lipotoxicity by increasing theexpression of Lipe. In addition, the expression of Ppargc1a wasincreased to increase mitochondrial synthesis and worsen thymic cancer.

FIG. 2 shows the weight of thymi extracted at a time point (day 100)when AKR/J mice started to die of thymic cancer during their housingafter AKR/J and ICR mice were irradiated with a high level of radiation(0.8 Gy/min). According to the present invention, fatty acidmetabolism-related genes that respond sensitively to a high level ofradiation can be consistently measured by extracting thymi in an earlystage of cancer development in which mice start to die of thymic cancer,and comparing the weights of the extracted thymi.

1. A method for detecting a Acsl1 gene sensitive to a level of ionizingradiation, the method comprising the steps of: irradiating acancer-induced AKR/J mouse and an ICR mouse with a gamma radiation at adose rate of 0.8 Gy/min to a final dose of 4.5 Gy; extracting thymi fromthe AKR/J mouse and the ICR mouse; subjecting the thymi to a microarrayanalysis; selecting the Acsl1 gene as a fatty acid metabolism-relatedgene from the microarray analysis; and amplifying the Acsl1 gene andmeasuring an expression level of the gene.
 2. The method of claim 1,wherein the cancer is thymic cancer.
 3. The method of claim 1, furthercomprising the step of extracting the thymi a time point when the mousestarts to die of the cancer.
 4. The method of claim 1, wherein the stepof amplifying the Acsl1 gene uses primers having sequences set forth inSEQ ID NOS: 1 and 2.